The Perfect Storm Relationship Between Vaccination-induced Disorders and Illness Manifested by Post Covid-19 Long Haulers
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), the cause of coronavirus disease 2019 (Covid-19), has not only created an acute worldwide pandemic but also chronic adverse health effects in a substantial percentage of survivors. Hopefully, vaccines for Covid-19 will result in far fewer long haulers cases by reducing the severity of Covid-19 exposures. Acute and chronic vaccination-induced disorders attributable to Covid-19 immunizations need to be carefully assessed over intervals of several weeks because of the potential latency in mechanisms of disease causation that transcend anaphylaxis and allergic reactions.
References
Nath A. Long-Haul COVID. Neurology 2020; 95:559-560.
Kreye J, Reincke SM, Pruss H. Do cross-reactive antibodies cause neuropathology in COVID-19? Nature Reviews Immunology 2020; 20:645-646.
Wang EY, Mag T, Klein J et al. Diverse functional autoantibodies in patients with COVID-19. BMJ Yale 2020; doi 10.1101/2020.12.10.20247205.
Woodruff MC, Ramonell RP, Lee FEH, Sanz I. Broadly-targeted autoreactivity is common In severe SARS-COV-2 infection. MedRxiv 2020; doi 10.1101/2020.10.21.20216192.
Vadala M, Poddighe D, Laurino C et al. Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon? EPMA J 2017; 8:295-311.
Brawer AE. Hidden toxicity of human papillomavirus vaccine ingredients. J Rheumatic Dis Treatment 2019; 5:1-4.
Brawer AE. Vaccination induced diseases and their relationship to neurologic fatiguing syndromes, channelopathies, breast implant illness, and autoimmunity via molecular mimicry. Int J Vaccines Immunization 2020; 4:1-4.
Brawer AE, Sullivan DH. The expanding cocktail of harmful ingredients in human papillomavirus vaccines. Frontiers Women’s Health 2020; 5:1-4.
Dinse GE, Parks CG, Weinberg CR, et al. Increasing prevalence of antinuclear antibodies in the United States. Arth Rheumatol 2020; doi 10.1002/art.41214.
Bhushan I, Singh VK, Tripathi DK, eds. Nanomaterials and Environmental Biotechnology. Springer 2020; ISBN 978-3-030-34543-3.
Gordillo-Galeano A, Mora-Huertas CE, et al. Solid lipid nanoparticles and nanostructured lipid carriers: a review emphasizing on particle structure and drug release. Europ J Pharmaceut Biopharmaceut 2018; 133:285-308.
Bellavite P, Donzelli A. Adverse events following measels-mumps-rubella-varicella vaccine: an independent perspective on Italian pharmacovigilance data. F1000 Research 2021; 9:1176.
Pellegrino P, Carnovale C, Perrone V, et al. On the possible interaction between vaccines and drugs. Eur J Clin Pharm 2014; 70:369-371.
Correia MA, deMontellan PRO. Inhibition of Cytochrome P450 Enzymes. In “Cytochrome P450 Structure, Mechanism, and Biochemistry”, 3rd edition, Plenum Publishers, 2005.
Copyright (c) 2021 Journal of SARS-CoV-2 Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
